BeiGene(BGNE) - 2025 Q2 - Earnings Call Transcript
BeOne Medicines (BGNE) Q2 2025 Earnings Call August 06, 2025 08:00 AM ET Company ParticipantsDaniel Maller - VP - Investor RelationsJohn Oyler - Co-Founder, Chairman & CEOAaron Rosenberg - CFOLai Wang - Global Head of R&DMatt Shaulis - General Manager - North AmericaMark Lanasa - SVP & Chief Medical Officer - Solid TumorsSean Laaman - Executive DirectorYigal Nochomovitz - DirectorXiaobin Wu - President & COOReni Benjamin - Managing DirectorConference Call ParticipantsJessica Fye - MD & Equity Research Analy ...